Visit StreetInsider.com at http://www.streetinsider.com/Hot+FDA+News/Bristol-Myers+Squibb+%28BMY%29+FDA+Approves+Breyanzi+for+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukemia+or+Small+Lymphocytic+Lymphoma+/22934718.html for the full story.

Eins ist Fakt
Visit StreetInsider.com at http://www.streetinsider.com/Hot+FDA+News/Bristol-Myers+Squibb+%28BMY%29+FDA+Approves+Breyanzi+for+Relapsed+or+Refractory+Chronic+Lymphocytic+Leukemia+or+Small+Lymphocytic+Lymphoma+/22934718.html for the full story.